Skip to content

Meet us at COP31 · Startup Zone, Antalya, 9 to 20 NovemberRead more

Original disclosures,
open access.

Corporate sustainability reports for research and decisions.

Follow our research

Database

Sustainability reports
Countries
Exchanges
Sectors
Industries
Years
Statistics

Services

Reports
Packages
Solutions
Markdown
Enterprise licence
Coverage assurance
Download portal

About

About us
Clients
Research & news
Careers

Resources

Pricing
Questions & answers
API documentation
Contact
Become a Supporter

© 2026 SustainabilityReports.com. All rights reserved.

Privacy policy Terms of service

Imexpharm Corp 2024 Sustainability Report

Company: Imexpharm Corp

Sector: Manufacturing

Country: Vietnam

Year: 2024

Type: Sustainability Report

Pages: 124

Home
Imexpharm Corp
2024 Sustainability Report

Sustainability Report

Preview not available

Report overview

The report describes Imexpharm's 2024 growth, including gross revenue of VND 2,512.8 billion, total energy consumption of 59,606,649 MJ, and quantified Scope 1 and Scope 2 emissions. It also highlights workforce development, gender equality, occupational safety, and community programs, including VND 755 million in scholarships supporting over 220 students.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language
Pages
File size

Standards & Assurance

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Assurance

Statement included

ESG & Materiality

ESG data

Indicators available in this report:

Scope 1 emissions
Scope 2 emissions
Energy consumption
Water consumption
Waste
Employees
Women on the board
Workplace fatalities

Materiality

Assessment
Basis
Matrix

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown for your project.

Explore our services